Navigation Links
Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009
Date:4/15/2009

i>
  • XIENCE Nano - XIENCE V for small vessels in the U.S. This 2.25 diameter stent has been available in Europe since early 2008.
  • Bioabsorbable DES - DES that is gradually absorbed into the vessel wall - much like sutures are absorbed after healing a wound - with the potential to return the vessel to full motion. Abbott has the most advanced bioabsorbable DES clinical program, with an opportunity to reach the market years ahead of competitors.
  • Core products - Devices in active development include a next-generation bare metal stent, frontline and high-pressure balloons, and new guidewire.
  • Endovascular products - Self-expanding and balloon-expanding peripheral stents, including the Absolute Pro and Omnilink Elite Peripheral Stent Systems, and the Emboshield Nav6 Embolic Protection Device for carotid stenting.


    • '/>"/>
    SOURCE Abbott
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine news :

    1. Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
    2. Abbott Hosts Conference Call for First-Quarter Earnings
    3. Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter
    4. Abbott to Present at Cowen Annual Health Care Conference
    5. Abbott Announces Required Offer to Repurchase Convertible Senior Subordinated Notes of Its AMO Subsidiary
    6. Abbott Completes Acquisition of Advanced Medical Optics
    7. Abbott Opens New Pediatric Nutrition Manufacturing Facility in Singapore
    8. Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics
    9. Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics
    10. Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument
    11. Abbott Acquisition of Advanced Medical Optics Clears U.S. Antitrust Review
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/20/2013)... (PRWEB) May 20, 2013 A novel service ... Clinic . The company has been in the field of ... initiative will make sure that scholars are able to maintain ... service has three stages and has been priced at $1000. ... a dedicated mentor assigned to the project, who will handle ...
    (Date:5/20/2013)... Inspired by her client’s total weight loss ... , Shanna Layne came up with the charity idea “Our ... business host a clothing drive to support a local ... worth of clothing to Something Special, the local Montgomery County ... was a huge success. , Being a huge advocate and ...
    (Date:5/20/2013)... The report, "Gluten-Free Products Market ... Baking Mixes & Flour, Meat & Poultry Products), ... Global Trends & Forecasts To 2018" defines and ... and forecasting of the global revenue and volume ... and restraining factors for the global gluten-free product ...
    (Date:5/20/2013)... Nordic Naturals®, the leading manufacturer of omega-3 ... powerful EPA-only concentrates available without a prescription. With 1600 ... serving, EPA Elite provides high intensity, therapeutic support for ... anti-inflammatory pathways. , EPA Elite is an EPA-only ... to a much-studied ethyl-ester EPA formulation. This dose of ...
    (Date:5/20/2013)... My Fit Foods continues its ... location bringing the healthy grab and go concept to the ... Foods store, located at 7979 N. Macarthur Blvd. Suite 110, ... snacks for the taking. , My Fit Foods was founded ... Mendias, a former Marine and Houston personal trainer who was ...
    Breaking Medicine News(10 mins):Health News:Dissertation Clinic Prescribes Customized Remedy for Researchers 2Health News:Spring and The Woodlands Personal Training Centers Held Successful “Our Loss Their Gain” Clothing Drive to Help Local Women’s Center 2Health News:Spring and The Woodlands Personal Training Centers Held Successful “Our Loss Their Gain” Clothing Drive to Help Local Women’s Center 3Health News:Gluten-Free Products Market to Reach $6,206.2 Million by 2018 at a CAGR of 10.2% - New Report by MarketsandMarkets 2Health News:Gluten-Free Products Market to Reach $6,206.2 Million by 2018 at a CAGR of 10.2% - New Report by MarketsandMarkets 3Health News:Nordic Naturals Launches Innovative EPA Elite™ 2Health News:My Fit Foods Opens a New Retail Location in Las Colinas Thursday, May 23rd 2
    ... targeted therapy against the BRAF/MAPK pathway with immunotherapy shows ... of melanoma, according to results of a preclinical study ... the American Association for Cancer Research. "Our results ... therapy and immunotherapy in the treatment of this most ...
    ... Center in Hamburg, Germany successfully used transcatheter valve-in-valve implantation ... mitral position. This minimally invasive procedure was used ... at high surgical risk. Full details of the ... Catheterization and Cardiovascular Interventions , a journal published by ...
    ... more likely to underestimate their preschool children,s weight when ... or gaining weight too fast, a study by the ... The study, published online earlier this ... not hesitate to wield their influence in helping parents ...
    ... ... holistically reverse symptoms associated with Polycystic Ovarian Syndrome and Insulin Resistance in her e-book. ... (PRWEB) ... are now able to lose weight and achieve hormonal balance without taking any prescription ...
    ... male-only protein found in rats helps control stress signals in ... -- When it comes to stress, women are twice as ... and/or post-traumatic stress, and now a new study in rats ... evidence in animals that suggests that males benefit from having ...
    ... Journal of Thoracic Oncology features a study aimed ... nab-paclitaxel with carboplatin as a first-line therapy in patients ... researchers with a data needed to guide a phase ... for patients with NSCLC is carboplatin plus solvent-based paclitaxel. ...
    Cached Medicine News:Health News:Combined BRAF-targeted and immunotherapy shows promise for melanoma treatment 2Health News:Elderly patients in need of heart valve replacements have alternative to surgery 2Health News:Pediatricians can help parents recognize overweight preschoolers 2Health News:Pediatricians can help parents recognize overweight preschoolers 3Health News:Women with Polycystic Ovarian Syndrome and Insulin Resistance can Lose Weight and Balance Hormones Naturally with Katie Humphrey's New E-book 2Health News:Females May Be Naturally More Prone to Stress: Animal Study 2Health News:Novel paclitaxel formulation encouraging for treating advanced lung cancer 2
    (Date:5/17/2013)... , May 17, 2013 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will ... March 31, 2013, before market on Tuesday, May 28, 2013.  ... 28, 2013, at 8:00 a.m. EDT (May 28, 2013 at ... results and provide an update on recent corporate developments. ...
    (Date:5/16/2013)... , May 17, 2013 ... and Switzerland,s Cytos Biotechnology AG today ... a Phase 1 clinical trial with their H1N1 influenza vaccine ... technology. In this first Phase 1 clinical trial, the safety ... to protect against H1N1 influenza infection will be evaluated. ...
    (Date:5/16/2013)...  PTC Therapeutics, Inc., today announced that it has ... U.S. Securities and Exchange Commission ("SEC") relating to the ... number of shares to be offered and the price ... (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) J.P. ... managers for the offering. Cowen and Company is acting ...
    Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
    ... Mich., Jan. 23, 2012 Perrigo Company (Nasdaq: PRGO;TASE) announced ... Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine ... the owner of the New Drug Application (NDA) of its ... Impax Laboratories, Inc. (Nasdaq: IPXL ), who will ...
    ... (OTC: PLCSF), a company focused on innovative medical device ... in the CIN-RG trial, the company,s pivotal trial to ... System™ in the prevention of Contrast-Induced Nephropathy (CIN).  This ... regulatory approval by the U.S. Food and Drug Administration ...
    Cached Medicine Technology:Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals 2Perrigo Confirms Filing for Generic Version of Astepro® Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals 3First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial 2First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial 3
    ... provides anterior column support for single or ... to L5. The system consists of one ... that are stacked to a desired height, ... Fiber Reinforced Polymer material emulates the biomechanical ...
    ... in interbody fusion are to ... restore disc space height and ... an enviroment for bone fusion ... Allograft is designed to promote ...
    ... highly adaptable and therefore suitable for a ... its extraordinary small outer diameter and the ... a simple but secure and reliable fixation ... instruments around the corner. These characteristics make ...
    A new flexible endoscope with an ultra dense optic fiber system. Its two working and irrigation channels and steering mechanism makes it ideal for a multipurpose use in neurosurgical endoscopy i.e. V...
    Medicine Products: